Learn more
Join Dexa

Pharma Accountability

Aseem discusses the troubling history of pharmaceutical companies, highlighting how financial incentives have led to significant ethical breaches. He emphasizes the need for accountability among top executives, suggesting that personal consequences could deter future misconduct. The conversation also delves into the complexities surrounding myocarditis and the misinterpretation of data related to vaccines and COVID, revealing the importance of rigorous diagnostic criteria.